Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.94 USD | +1.19% | +10.61% | -2.14% |
Financials (USD)
Sales 2024 * | 2.6B | Sales 2025 * | 2.73B | Capitalization | 1.83B |
---|---|---|---|---|---|
Net income 2024 * | 14M | Net income 2025 * | 22M | EV / Sales 2024 * | 1.59 x |
Net Debt 2024 * | 2.3B | Net Debt 2025 * | 2.09B | EV / Sales 2025 * | 1.44 x |
P/E ratio 2024 * |
119
x | P/E ratio 2025 * |
66
x | Employees | 7,850 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 26.94% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | +1.19% | ||
1 week | +10.61% | ||
Current month | -1.98% | ||
1 month | -1.98% | ||
3 months | +3.12% | ||
6 months | +57.56% | ||
Current year | -2.14% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 5.94 | +1.19% | 1,265,326 |
24-04-26 | 5.87 | -0.51% | 959,058 |
24-04-25 | 5.9 | -2.48% | 3,428,210 |
24-04-24 | 6.05 | +12.04% | 3,066,491 |
24-04-23 | 5.4 | +0.56% | 1,382,090 |
Delayed Quote Nasdaq, April 29, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.14% | 1.83B | |
+26.47% | 664B | |
+26.74% | 567B | |
-6.33% | 354B | |
+19.35% | 330B | |
+4.23% | 286B | |
+13.43% | 234B | |
+4.71% | 199B | |
-9.53% | 196B | |
-4.04% | 148B |
- Stock Market
- Equities
- AMRX Stock